Brain Support
NDC 62185-0051, Acetylcholine Chloride, Taurine, Adenosinum Cyclophosphoricum, Cerebrum (Suis), Diencephalon (Suis), Pineal Gland (Suis), Thalamus Opticus (Suis), Adrenalinum, Dopamine Hydrochloride, GABA (Gamma-Aminobutyric Acid), Norepinephrine (Bitartrate), Serotonin (Hydrochloride), Tyramine, liquid, from Dr. Donna Restivo DC.
- Product NDC
- 62185-0051
- Status
- Listed
- Labeler
- Dr. Donna Restivo DC
- Dosage form
- LIQUID
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/62185-0051 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ACETYLCHOLINE CHLORIDE6 [hp_X]/mL
- TAURINE6 [hp_X]/mL
- ADENOSINE CYCLIC PHOSPHATE8 [hp_X]/mL
- SUS SCROFA CEREBRUM8 [hp_X]/mL
- SUS SCROFA DIENCEPHALON8 [hp_X]/mL
- SUS SCROFA PINEAL GLAND8 [hp_X]/mL
- SUS SCROFA THALAMUS LATERAL GENICULATE NUCLEUS8 [hp_X]/mL
- EPINEPHRINE8 [hp_X]/mL
- DOPAMINE HYDROCHLORIDE8 [hp_X]/mL
- .GAMMA.-AMINOBUTYRIC ACID8 [hp_X]/mL
- NOREPINEPHRINE BITARTRATE8 [hp_X]/mL
- SEROTONIN HYDROCHLORIDE8 [hp_X]/mL
- TYRAMINE8 [hp_X]/mL
Pharmacologic classes
Adrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Catecholamine [EPC]; Catecholamine [EPC]; Catecholamine [EPC]; Catecholamines [CS]; Catecholamines [CS]; Catecholamines [CS]; Cholinergic Agonists [MoA]; Cholinergic Receptor Agonist [EPC]; alpha-Adrenergic Agonist [EPC]; beta-Adrenergic Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 62185-0051-1 | 62185005101 | 30 mL in 1 BOTTLE, DROPPER (62185-0051-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 62185-0051 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/62185-0051 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 62185-0051. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.